Bryce Vissel

Add links
From Wikipedia, the free encyclopedia

Bryce Vissel

Bryce Vissel is an Australian neuroscientist[1][2][3][4] who is a professor of neuroscience at the University of New South Wales. He is the Director of the Centre for Neuroscience and Regenerative Medicine (CNRM) at St Vincent's Hospital Sydney.[5] He is a specialist in neurodegenerative diseases, such as Alzheimer's, Parkinson's, and the neural basis of learning, memory and movement.

Career[edit]

After achieving his PhD in medical genetics at the University of Melbourne[6][7][citation needed] Vissel joined the Garvan Institute's Neuroscience Division. He was subsequently awarded a NHMRC CJ Martin Fellowship[8] to pursue neuroscience research with Stephen Heinemann at the Salk Institute.[9] At Salk, Vissel authored studies describing molecular mechanisms that regulate synaptic function, and the role of these mechanisms in behaviour, learning and memory, and neurological diseases. He also received a Human Frontiers Program Award[10] and a Fulbright Award.[11]

In 2002, Vissel returned to Garvan, taking up a position as Head of the Neurodegenerative Diseases Group before being recruited by UTS.[citation needed] Vissel and UTS established the CNRM in 2017.[12] Incorporating facilities in Botany and St Vincent's Hospital, the Centre focused on research of the brain and spinal cord. In 2021, Vissel and CNRM moved to St Vincent's Hospital Sydney where the research effort continues.

Under Vissel's leadership, the CNRM's Brain Regeneration Program has shown that repair appears possible in the Ca1 and CA3 regions of the hippocampus, the brain's memory centre.[13] These findings have potential to impact treatment of a range of diseases through stimulating the brain's regenerative mechanisms, including Parkinson's,[14] Alzheimer's, and other devastating conditions.

Vissel was instrumental in introducing UCLA-based scientist Professor Reggie Edgerton's[15] pioneering work on spinal cord injuries to Australia,.[16][17][18][19]

Vissel was also previously chair of the advisory board of Cellmid Ltd, a position he held since July 2015.[20]

References[edit]

  1. ^ Bowler, Jacinta (April 2017). "We Finally Have Some New Insight Into How PTSD Occurs in The Brain". ScienceAlert. Retrieved 25 March 2019.
  2. ^ "Tau tangles damage brain GPS in Alzheimer's disease". Cosmos Magazine. Retrieved 25 March 2019.
  3. ^ "New drug target raises hopes for Alzheimer's and ALS treatment". Cosmos Magazine. Retrieved 25 March 2019.
  4. ^ Smith, Belinda (6 April 2018). "Does your brain stop making new cells once you're an adult?". ABC News. Retrieved 25 March 2019.
  5. ^ "Welcome to our new Neurosciences Research Team - St Vincent's Curran Foundation". Supportstvincents.com.au. Retrieved 12 August 2022.
  6. ^ "Bryce Vissel - Scimex". www.scimex.org. Retrieved 11 March 2019.
  7. ^ "Bryce Vissel PhD". The Michael J. Fox Foundation for Parkinson's Research | Parkinson's Disease. Retrieved 11 March 2019.
  8. ^ "The role of glutamate receptor mediated excititoxicity in neurodegeneration and Huntington's disease". Research Data Australia. Retrieved 15 February 2019.
  9. ^ "Bryce Vissel - Scimex". www.scimex.org. Retrieved 15 February 2019.
  10. ^ Götz, Jürgen; Schonrock, Nicole; Vissel, Bryce; Ittner, Lars M. (26 August 2009). "Alzheimer's Disease Selective Vulnerability and Modeling in Transgenic Mice". Journal of Alzheimer's Disease. 18 (2): 243–251. doi:10.3233/jad-2009-1143. ISSN 1875-8908. PMID 19584440.
  11. ^ "Bryce Vissel PhD". The Michael J. Fox Foundation for Parkinson's Research | Parkinson's Disease. Retrieved 15 February 2019.
  12. ^ Han, Esther (3 December 2017). "New trial aiming to repair injured spinal cords gives new hope to paralysed Australians". The Sydney Morning Herald. Retrieved 15 February 2019.
  13. ^ Abdipranoto-Cowley, A.; Park, J. S.; Croucher, D.; Daniel, J.; Henshall, S.; Galbraith, S.; Mervin, K.; Vissel, B. (2009). "Activin A Is Essential for Neurogenesis Following Neurodegeneration". Stem Cells. 27 (6): 1330–46. doi:10.1002/stem.80. PMC 2733378. PMID 19489097.
  14. ^ Stayte, Sandy; Vissel, Bryce (19 August 2014). "Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease". Frontiers in Neuroscience. 8: 254. doi:10.3389/fnins.2014.00254. ISSN 1662-453X. PMC 4137258.
  15. ^ SCIMEX (26 April 2018). "Patients with severe paralysis regain use of hands and fingers for improved quality of life". Scimex. Retrieved 15 February 2019.
  16. ^ "9Now - Watch Channel 9 Live and on Demand". www.9now.com.au. Retrieved 24 April 2019.
  17. ^ "New trial aiming to repair injured spinal cords gives new hope to paralysed Australians". 3 December 2017.
  18. ^ Khan, Jo (1 November 2018). "Swiss study gets three paraplegic patients on their feet again". ABC News. Retrieved 15 February 2019.
  19. ^ Strom, Marcus (16 September 2016). "Hope for the paralysed: UTS to establish Centre for Neuroscience and Regenerative Medicine". The Sydney Morning Herald. Retrieved 15 February 2019.
  20. ^ "Cellmid appoints Dr Bryce Vissel as chairman of scientific advisory board". Proactiveinvestors UK. 8 July 2015. Retrieved 15 February 2019.


Flag of AustraliaBiography icon

This biography of an Australian academic is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Bryce_Vissel&oldid=1190687657"